1-[3-(2-Chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]-6-methyl-1,2,3,4-tetrahydroquinoline

Catalog No. :
ACVWJS319
CAS No. :
1024388-13-3
Molecular Formula :
C21H19ClN2O2
Molecular Weight :
366.85

IUPAC Name:(3-(2-chlorophenyl)-5-methylisoxazol-4-yl)(6-methyl-3,4-dihydroquinolin-1(2H)-yl)methanone

1-[3-(2-Chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]-6-methyl-1,2,3,4-tetrahydroquinoline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$288.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-[3-(2-Chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]-6-methyl-1,2,3,4-tetrahydroquinoline
IUPAC Name(3-(2-chlorophenyl)-5-methylisoxazol-4-yl)(6-methyl-3,4-dihydroquinolin-1(2H)-yl)methanone
MDL No.MFCD00245633
Molecular FormulaC21H19ClN2O2
Molecular Weight366.85
SMILESCC1=CC2=C(N(C(C3=C(C)ON=C3C4=CC=CC=C4Cl)=O)CCC2)C=C1
InChI KeyMCCDKIFSUPSJCX-UHFFFAOYSA-N
Synonym3-(2-CHLOROPHENYL)-5-METHYLISOXAZOL-4-YL 6-METHYL(1,2,3,4-TETRAHYDROQUINOLYL) KETONE;1-[3-(2-chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]-6-methyl-1,2,3,4-tetrahydroquinoline;Methanone, [3-(2-chlorophenyl)-5-methyl-4-isoxazolyl](3,4-dihydro-6-methyl-1(2H)-quinolinyl)-
CAS No.1024388-13-3

Synthetic Route by SureRoute

1. ACVWJS319 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSQJY175 route compound structure diagram
    ACSQJY17591-61-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVWJS319 route product structure diagram
    ACVWJS3191024388-13-3
Inquiry

2. ACVWJS319 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSQJY175 route compound structure diagram
    ACSQJY17591-61-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVWJS319 route product structure diagram
    ACVWJS3191024388-13-3
Inquiry

Comments (0)